Manufacturing plasma-derived medicinal products
In the highly specialised field of plasma-derived medicinal products, LFB draws on its pharmaceutical and industrial expertise and know-how to develop its work in technology transfer.
Major collaboration in Brazil
Since 2007 the first technology transfer has been undertaken with the Brazilian State-owned company HEMOBRAS. For this, a plasma fractionation facility is being constructed in northern Brazil. This plant will allow essential medicinal products to be manufactured in Brazil, from plasma collected within the country.
There are ongoing technology transfer projects with partners in Poland and Malaysia.